Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of Itraconazole in Patients with Advanced HIV Infection Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Study of Itraconazole in Patients with Advanced HIV Infection conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Study of Itraconazole in Patients with Advanced HIV Infection Clinical research trials and Study of Itraconazole in Patients with Advanced HIV Infection healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Study of Itraconazole in Patients with Advanced HIV Infection. Study of Itraconazole in Patients with Advanced HIV Infection Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study of Itraconazole in Patients with Advanced HIV Infection clinical trial. Test subjects typically receive the most effective healthcare possible for their Study of Itraconazole in Patients with Advanced HIV Infection condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study of Itraconazole in Patients with Advanced HIV Infection

Study of Itraconazole in Patients with Advanced HIV Infection



Study of Itraconazole in Patients with Advanced HIV Infection

For Condition: HIV Infections
Status: Completed
Sponsor(s): Janssen Pharmaceutica ,
Synopsis: To demonstrate a dosage regimen for intravenous itraconazole that produces a plasma concentration range comparable to that obtained after currently used oral dosages of itraconazole oral solution; and to obtain preliminary safety data in patients with advanced HIV disease.
Details: Patients will receive intravenous itraconazole solution twice daily for 2 days and then once daily for five additional days. Patients then randomized to receive twice-daily or once-daily itraconazole oral solution for an additional 28 days.
Eligibility:
Study Type:  Interventional, Treatment, Dose Comparison, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Concurrent Medication: Allowed: Antiretroviral therapy providing patient has already been on a stable, unchanged regimen for 8 weeks prior to study entry. Patients must have: - Documented HIV infection. - CD4 lymphocyte count < 300 cells/mm3. - No clinically significant abnormalities, elicited by history and physical examination. - No clinically significant abnormalities in blood count, biochemical profile, or urinalysis within 2 weeks of study entry. - Negative urine screening. - No clinically significant abnormalities of electrocardiogram. Prior Medication: Allowed: Antiretroviral therapy providing patient has been on a stable, unchanged regimen for 8 weeks prior to study entry. Exclusion Criteria Co-existing Condition: Patients with the following symptoms and conditions are excluded: - Acute opportunistic infection or other significant concurrent illness that would preclude participation for the required 36 days. - Unable to swallow oral solution. - Obesity greater than 25% of ideal body weight. Concurrent Medication: Excluded: - Rifampin. - Rifabutin. - Phenobarbital. - Phenytoin. - Carbamazepine. - Digoxin. - Warfarin. - Midazolam. - Triazolam. - Terfenadine. - Astemizole. - Cisapride. - H2 blockers. - Omeprazole. - Continual antacids. - Didanosine. - Any medication known to affect absorption, metabolism or excretion of imidazole or azole compounds. Patients with the following prior symptoms and conditions are excluded: - Previous hypersensitivity to azole antifungals. - History of surgical procedure that may interfere with absorption of itraconazole. - History of significant blood loss in the previous 30 days. Prior Medication: Excluded: Excluded within 15 days prior to study entry: - Rifampin. - Rifabutin. - Phenobarbital. - Phenytoin. - Carbamazepine. - Digoxin. - Warfarin. - Midazolam. - Triazolam. Excluded within 8 weeks prior to study entry: - Change in antiretroviral therapy. Risk Behavior: Excluded: Patients who chew tobacco or regularly smoke more than 10 cigarettes per day.
Total Enrollment: 36

Location and Contact Information:

Erie County Med Ctr / Pharmacy D
Buffalo,  New York,  14215
United States
 


Additional Information:
Study ID Numbers:  254B; 
Study Start Date: 
Record last reviewed: August 1997
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002370

Other Hiv Infections Studies:
1. A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children

2. A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis carinii Pneumonia in AIDS

3. Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients

4. The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined with Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

5. A Study of Tecogalan Sodium

Related Studies:

Other HIV Infections Clinical Trials
Other New York Clinical Trials
Other Buffalo Clinical Trials

Study of Itraconazole in Patients with Advanced HIV Infection
Modify your Search

  Other HIV Infections Clinical Trials
  Other New York Clinical Trials
  Other Buffalo Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103